Clinical trial
US Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus
NCT05232838 is registered in ClinicalTrials.gov with CereVasc Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- US Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus
- Lead sponsor
- CereVasc Inc
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 20, 2022
- Completion date
- June 30, 2030
- Enrollment
- 50 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.